Phase II, open-label, prospective single-arm, multi-center clinical trial to evaluate if adding Venetoclax to patients on covalent BTKI for 1L CLL can achieve deep durable remissions (by uMRD 10^-4) to allow off-treatment period

MyChart

Log in to our secure, personalized website to manage your care (formerly myMDAnderson).
Request an Appointment

If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson’s appointment process, our information page may be the best place to start.
Appointment Information

New Patients Current Patients Referring Physicians
Donate Today